Cargando…
Association of proton pump inhibitor and histamine H(2)-receptor antagonists with restless legs syndrome
Restless legs syndrome (RLS) is a common sensorimotor disorder, which can disrupt sleep and is thought to be caused in part by low cellular iron stores. Proton pump inhibitors (PPI) and histamine H(2)-receptor antagonists (H(2)A) are among the most commonly used drugs worldwide and show evidence of...
Autores principales: | Earley, Eric J, Didriksen, Maria, Spencer, Bryan R, Kiss, Joseph E, Erikstrup, Christian, Pedersen, Ole B, Sørensen, Erik, Burgdorf, Kristoffer S, Kleinman, Steven H, Mast, Alan E, Busch, Michael P, Ullum, Henrik, Page, Grier P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033459/ https://www.ncbi.nlm.nih.gov/pubmed/33119070 http://dx.doi.org/10.1093/sleep/zsaa220 |
Ejemplares similares
-
Striatal histamine mechanism in the pathogenesis of restless legs syndrome
por: Lai, Yuan-Yang, et al.
Publicado: (2019) -
Large genome-wide association study identifies three novel risk variants for restless legs syndrome
por: Didriksen, Maria, et al.
Publicado: (2020) -
Factors associated with augmentation in patients with restless legs syndrome
por: Heim, Beatrice, et al.
Publicado: (2021) -
High national rates of high-dose dopamine agonist prescribing for restless legs syndrome
por: Winkelman, John W
Publicado: (2021) -
Efficacy and safety of tonic motor activation (TOMAC) for medication-refractory restless legs syndrome: a randomized clinical trial
por: Bogan, Richard K, et al.
Publicado: (2023)